Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
US Army
Deloitte
Farmers Insurance
Chinese Patent Office
Queensland Health
Dow
McKinsey
Merck

Generated: December 16, 2018

DrugPatentWatch Database Preview

Akorn Company Profile

« Back to Dashboard

Summary for Akorn

Drugs and US Patents for Akorn

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn SULFACETAMIDE SODIUM sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 040216-001 May 25, 1999 DISCN No No ➤ Sign Up ➤ Sign Up
Akorn VORICONAZOLE voriconazole TABLET;ORAL 207049-002 Sep 7, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Akorn Inc APRACLONIDINE HYDROCHLORIDE apraclonidine hydrochloride SOLUTION/DROPS;OPHTHALMIC 077764-001 Mar 12, 2009 AT RX No No ➤ Sign Up ➤ Sign Up
Akorn AKTEN lidocaine hydrochloride GEL;OPHTHALMIC 022221-001 Oct 7, 2008 RX Yes Yes 8,759,401 ➤ Sign Up Y ➤ Sign Up
Akorn ATROPINE SULFATE atropine sulfate SOLUTION/DROPS;OPHTHALMIC 206289-001 Jul 18, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up
Akorn DESOXIMETASONE desoximetasone GEL;TOPICAL 090727-001 Mar 10, 2011 AB RX No No ➤ Sign Up ➤ Sign Up
Akorn DESOXIMETASONE desoximetasone CREAM;TOPICAL 203234-001 Jun 12, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Akorn

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Akorn ALFENTA alfentanil hydrochloride INJECTABLE;INJECTION 019353-001 Dec 29, 1986 4,167,574 ➤ Sign Up
Akorn SUFENTA PRESERVATIVE FREE sufentanil citrate INJECTABLE;INJECTION 019050-001 May 4, 1984 3,998,834 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for Akorn Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0822 Netherlands ➤ Sign Up PRODUCT NAME: RITUXIMAB EN RECOMBINANT HUMAAN HYALURONIDASE; REGISTRATION NO/DATE: EU/1/98/067/003 - UITVOERINGSBESLUIT C(2014)2048 20140326
/1997 Austria ➤ Sign Up PRODUCT NAME: ATORVASTATIN CALCIUM; NAT. REGISTRATION NO/DATE: 1-21926, 1-21927, 1-21928 19970411; FIRST REGISTRATION: GB PL 00018/0240 - PL 00018/0242 19961107
462 Luxembourg ➤ Sign Up PRODUCT NAME: BRIMONIDINE ET SES SELS PHARMACEUTIQUES POUR L UTILISATION COMME MEDICAMENT POUR LE TRAITEMENT DES ROUGEURS INDUITES PAR LA ROSACEA.FIRST REGISTRATION: 20140225
C0005 Belgium ➤ Sign Up PRODUCT NAME: FOSPHENYTOIN DISODIUM; NAT. REGISTRATION NO/DATE: NL 23 613 19980806; FIRST REGISTRATION: GB - PL 000 19/0157 19980204
00683 Netherlands ➤ Sign Up PRODUCT NAME: BRIMONIDINE EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN VOOR TOEPASSING ALS GENEESMIDDEL VOOR DE BEHANDELING VAN DOOR ROSACEA GEINDUCEERDE ROODHEID; REGISTRATION NO/DATE: EU/1/13/904 20140225
90031-1 Sweden ➤ Sign Up PRODUCT NAME: LATANOPROST
90064-1 Sweden ➤ Sign Up PRODUCT NAME: SIMEPREVIR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, INCLUDING SIMEPREVIR SODIUM; REG. NO/DATE: EU/1/14/924 20140516
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Deloitte
Boehringer Ingelheim
Farmers Insurance
Argus Health
Dow
Covington
US Department of Justice
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.